EANS-News: november AG / Publication of consolidated financial results for 2009 / Continued upswing of november AG

• improved operating profits despite reduced consolidated revenues
•
consolidated results virtually break-even with EUR –0.3 mio
•
reduction of liabilities from EUR 9.9 mio to EUR 6.9 mio
• increase
of equity capital from EUR –7.9 mio (2007), EUR –5.6 mio (2008) to
EUR –3.8 mio (2009)
• improved liquidity of EUR 0.7 mio

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

annual report/Annual Reports/annual result/Financial Figures/Balance
Sheet

Subtitle: • improved operating profits despite reduced consolidated
revenues • consolidated results virtually break-even with EUR –0.3
mio • reduction of liabilities from EUR 9.9 mio to EUR 6.9 mio •
increase of equity capital from EUR –7.9 mio (2007), EUR –5.6 mio
(2008) to EUR –3.8 mio (2009) • improved liquidity of EUR 0.7 mio

Köln (euro adhoc) - The november group, essentially consisting of the
november AG (holding) and the operating units PROGEN Biotechnik GmbH
and Multimetrix GmbH, achieved consolidated sales renues of EUR 5.3
mio (previous year EUR 8.1 mio) despite the discontinuation of the
Axis-Shield product line. Although sales revenues decreased due to
the transfer of this product range, the consolidated operating
results increased considerably from EUR -0.7 mio in 2008 to EUR -0.2
mio in fiscal year 2009. Thus, the restructuring of the november
group also shows positive results in other important operative
levels.

Same as previous year (EUR -0.2 mio), consolidated results nearly
reached break-even in fiscal year 2009 with EUR -0.3 mio. This
reflects the overall successful restructuring process of the november
group as well as the focus of the operating units on high-margin
products and profitable services. The consolidated financial results
improved considerably as compared to the previous year. Due to
continued restructuring of financial liabilities in 2009 and as a
result of interest waivers, the financial results improved to EUR
-0.1 mio in 2009 as compared to EUR -0.4 mio in 2008.

Liabilities were further decreased in 2009 as compared to the
previous year (2009: EUR 6.9 mio, 2008: EUR 9.9 mio). Accordingly,
the total equity increased considerably to EUR -3.8 mio as compared
to previous years (2008: EUR -5.7 mio, 2007: EUR -7.9 mio).
Additional measures were implemented already in the fist quarter of
2010 to further reduce liabilities of the group. For results and
comments, please refer to the 1st quarter report 2010. For fiscal
year ending December 31, 2009 the november group shows a liquidity of
approx. EUR 0.7 mio despite significant loan repayments.

Please refer to the consolidated management report 2009 including all
certified financial results under
www.november.eu/company-profile/reports.html.

Presentation of corporate business results for fiscal year 2009 at
the next annual general meeting of the november AG which is planned
for July 21, 2010 in Cologne.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: november AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Christoph Schmitz

Leiter Finanzen, Controlling

Tel.: +49 (0) 221- 820 05 20 -10

E-Mail: info@november.de

Branche: Biotechnology
ISIN: DE000A0Z24E9
WKN: A0Z24E
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade